By Douglas Feil, Chief Program Officer, National Breast Cancer Foundation (NBCF) In recent years, Glucagon-like peptide-1 (GLP-1)...
Layla Zulfa
The marriage of artificial intelligence and drug discovery has long been touted as the "next frontier" of...
For decades, the European continent has been the bedrock of oncology research, a bastion of scientific excellence...
More than a decade after the Affordable Care Act (ACA) was signed into law, the landscape of...
NEW YORK, NY — As the world enters the second week of October, a month traditionally synonymous...
In a landmark study that challenges the conventional understanding of cellular respiration, researchers at the Broad Institute...
Europe, historically the bedrock of modern medical innovation and the cradle of oncology research, is facing a...
MADRID, Spain – As the global medical community prepares to converge in the historic city of Madrid...
MADRID, Spain – As the global oncology community converges on the historic city of Madrid for the...
Metastatic breast cancer (mBC)—clinically classified as Stage IV breast cancer—represents the most advanced form of the disease....
